These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30878325)

  • 21. Is medical abortion acceptable to all American women: the impact of sociodemographic characteristics on the acceptability of mifepristone-misoprostol abortion.
    Clark S; Ellertson C; Winikoff B
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):177-82. PubMed ID: 10846333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences.
    Fielding SL; Edmunds E; Schaff EA
    Perspect Sex Reprod Health; 2002; 34(1):34-40. PubMed ID: 11990637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Situation analysis of patients attending TU Teaching Hospital after medical abortion with problems and complications.
    Ojha N; Bista KD
    JNMA J Nepal Med Assoc; 2013; 52(191):466-70. PubMed ID: 24907952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early pregnancy termination with mifepristone and misoprostol in Norway.
    Bjørge L; Johnsen SL; Midbøe G; Augestad G; Økland I; Helland H; Stray-Pedersen S; Iversen OE
    Acta Obstet Gynecol Scand; 2001 Nov; 80(11):1056-61. PubMed ID: 11703208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial.
    Shaw KA; Shaw JG; Hugin M; Velasquez G; Hopkins FW; Blumenthal PD
    Contraception; 2015 Apr; 91(4):313-9. PubMed ID: 25499589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
    Baird DT; Sukcharoen N; Thong KJ
    Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
    Gatter M; Cleland K; Nucatola DL
    Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion.
    Schaff EA; Eisinger SH; Stadalius LS; Franks P; Gore BZ; Poppema S
    Contraception; 1999 Jan; 59(1):1-6. PubMed ID: 10342079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study.
    Goldstone P; Michelson J; Williamson E
    Med J Aust; 2012 Sep; 197(5):282-6. PubMed ID: 22938126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medical termination of early pregnancy: the Swedish experience.
    Bygdeman M; Danielsson KG; Marions L
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):195-6, 204. PubMed ID: 10846338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
    Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
    PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current medical abortion care.
    Creinin MD
    Curr Womens Health Rep; 2003 Dec; 3(6):461-9. PubMed ID: 14613667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical uses of mifepristone: an update for women's health practitioners.
    Beal MW; Simmonds K
    J Midwifery Womens Health; 2002; 47(6):451-60. PubMed ID: 12484667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes and preferences toward the provision of medication abortion in an urban academic internal medicine practice.
    Page C; Stumbar S; Gold M
    J Gen Intern Med; 2012 Jun; 27(6):647-52. PubMed ID: 22223135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial.
    Howie FL; Henshaw RC; Naji SA; Russell IT; Templeton AA
    Br J Obstet Gynaecol; 1997 Jul; 104(7):829-33. PubMed ID: 9236649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical methods of early abortion in developing countries. Consensus statement. The Population Council.
    Contraception; 1998 Nov; 58(5):257-9. PubMed ID: 9883380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility, efficacy, safety, and acceptability of mifepristone-misoprostol for medical abortion in the Democratic People's Republic of Korea.
    Tran NT; Jang MC; Choe YS; Ko WS; Pyo HS; Kim OS
    Int J Gynaecol Obstet; 2010 Jun; 109(3):209-12. PubMed ID: 20206354
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extending outpatient medical abortion services through 70 days of gestational age.
    Winikoff B; Dzuba IG; Chong E; Goldberg AB; Lichtenberg ES; Ball C; Dean G; Sacks D; Crowden WA; Swica Y
    Obstet Gynecol; 2012 Nov; 120(5):1070-6. PubMed ID: 23090524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy interruption using mifepristone (RU-486). A new choice for women in the USA.
    Mackenzie SJ; Yeo S
    J Nurse Midwifery; 1997; 42(2):86-90. PubMed ID: 9107115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.